Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021

ALXN Articles

The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The July 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves...
The May 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The April 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The top analyst upgrades, downgrades and other research calls from Monday include Apple, Chevron, FirstEnergy, Intel, Kinder Morgan, Mattel, Sprint, T-Mobile, Take-Two Interactive Software and...
Alexion Pharmaceuticals released better-than-expected first-quarter financial results before the markets opened on Thursday.
The April 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and biotech companies reporting their latest quarterly results in the coming week.
These four top Suntrust biotech picks for 2018 all have the potential for big upside moves if they do indeed exceed first-quarter expectations.
The March 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.